ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
4465	Centers for Disease Control and Prevention	Html	en	CDC Features - Vaccine Safety | CDC Features	The United States has one of the best vaccine safety programs in the world. CDC and the U.S. Food and Drug Administration (FDA) are federally mandated to monitor the safety of vaccines. Scientists are constantly monitoring information from several sources for any clues that a particular vaccine may cause an adverse medical event, such as an allergic reaction.	injection sight 0.299054 media stories 0.318731 federal government 0.303125 results 0.237915 laboratory studies 0.305456 government agencies 0.302388 greater risk 0.297074 additional testing 0.308213 VSD 0.225525 Vaccine Adverse Event 0.578537 blog postings 0.316371 Slight discomfort 0.308842 effects 0.283619 scientists 0.264462 programs 0.221283 different vaccines 0.554643 important things 0.310819 Scientific data 0.297955 FDA 0.238157 vaccines 0.944085 United States 0.511586 adverse medical event 0.451137 Clinical trials 0.309653 Drug Administration 0.307873 multiple vaccines 0.491968	best vaccine safety 0.614797 quickest protection 0.304459 combination vaccines 0.585585 world 0.221272 responsibility 0.23678 systems 0.234777 local health departments 0.390003 VAERS 0.322732 allergic reaction 0.318768 safeguards 0.222854 multiple diseases 0.295861 vaccine safety monitoring 0.523651 animal studies 0.305398 medicine 0.239051 adverse events 0.428231 Vaccine Safety Datalink 0.564911 vaccine safety 0.804926 particular vaccine 0.500697 healthcare provider 0.299878 partners 0.235021 report 0.246335 combined MMRV vaccine 0.518959 information 0.22119 visit 0.231563	CLICK HERE
7932	Centers for Disease Control and Prevention	Html	en	Published Reports of Delayed Hemolytic Anemia AfterTreatment with Artesunate for Severe Malaria - Worldwide,2010-2012	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	red blood cells 0.456338 hemolysis 0.559048 CDC Malaria Branch 0.540567 Materiel Development Activity 0.465429 reported parasitemia 0.452963 first-line treatment 0.473955 ring-infected erythrocyte surface 0.452303 unparasitized RESA-positive RBCs 0.479808 World Health Organization 0.465405 nonendemic countries 0.459615 artesunate 0.568941 mean cumulative dose 0.503754 patients 0.604793 severe anemia 0.475981 Paul M. Arguin 0.456851 packed RBCs 0.463338 mean hemoglobin nadir 0.489566 parasite clearance 0.523007 delayed hemolysis 0.477318 treatment 0.538183 delayed hemolytic events 0.529144 severe malaria 0.914536 United States 0.774646 mean highest parasitemia 0.465792	good manufacturing practice 0.454522 artesunate-treated RBCs 0.459786 delayed postartesunate treatment 0.485835 peer-reviewed medical literature 0.462664 manufacturing site assessment 0.454143 artesunate therapy 0.553437 severe malaria patients 0.556323 travel-associated severe malaria 0.543841 initial clinical improvement 0.458298 cases 0.466489 CDC IND protocol 0.462256 RBCs 0.495752 complete parasite clearance 0.45911 typical hemoglobin nadir 0.475094 artesunate IND protocol 0.482146 U.S. artesunate 0.457063 healthy RBCs 0.457493 additional case reports 0.462224 acute malaria 0.499959 glucose-6-phosphate dehydrogenase deficiency 0.45421 multiple hemoglobin measurements 0.481867 elevated lactate dehydrogenase 0.460566 delayed hemolytic anemia 0.539312 Melissa Briggs 0.454573	CLICK HERE
8848	Centers for Disease Control and Prevention	Html	en	Risk Assessment and Biosafety Level RecommendationsInfluenza A H7N9	Interim Risk Assessment and Biosafety Level Recommendations for Working With Influenza A(H7N9) Viruses - CDC	H7N9 viruses 0.486755 low-pathogenicity avian influenza 0.521338 avian influenza 0.724031 antiviral agents 0.499452 laboratory workers 0.501763 avain influenza 0.49607 avian influenza viruses 0.594765 novel influenza 0.565285 human influenza viruses 0.5897 wild type influenza 0.556002 influenza virus vaccine 0.536097 J.J. Influenza virus 0.529153 influenza A viruses 0.528594 laboratory personnel 0.495254 primary containment device 0.483714 influenza disease 0.522104 convalescent serum samples 0.488378 H7N9 virus transmission 0.480391 H7 subtype viruses 0.550222 pathogenic avian influenza 0.571665 wild type virus 0.484115 potential occupational exposure 0.483077 seasonal influenza vaccine 0.53685	avian influenza H7N3 0.52367 respiratory protection 0.514977 airborne influenza virus 0.52761 Anonymous. Avian influenza 0.521121 avian influenza lineage 0.550832 influenza vaccines 0.508998 avian influenza virus 0.571145 H7N3 influenza vaccine 0.526967 inactivated avian influenza 0.523841 J. Avian influenza 0.523507 uncomplicated influenza illness 0.520033 Infectious influenza virus 0.551295 influenza H7 virus 0.545133 biological safety cabinets 0.495055 virus infection 0.481396 human infections 0.504265 influenza viruses 0.636895 laboratory 0.536054 H9N2 avian influenza 0.541245 virulent H5N1 influenza 0.508764 Eurasian avian influenza 0.54069 current seasonal influenza 0.517752 Eurasian H7 viruses 0.479799	CLICK HERE
9365	Centers for Disease Control and Prevention	Html	es	Prevalencia de ciertos factores de riesgo de enfermedades crónicas no transmisibles en Jordania: Resultados de la Encuesta del 2007 sobre Vigilancia de Factores de Riesgo del Comportamiento en Jordania	CDC - Wide Page example description goes here	Brown DW 0.563983 Zindah M 0.557486 Organización Mundial 0.540234 disease risk factors 0.745965 Walke H 0.559141 risk factor 0.929172 reportó tensión 0.539732 adultos jordanos 0.575603	Factor Surveillance Survey 0.702162 Hadaddin R 0.557377 Belbeisi A 0.556087 Jordan Behavioral Risk 0.754267 salud pública 0.740807 determinadas afecciones 0.588898 reportó hipertensión 0.598322 Chronic Dis 0.58998	CLICK HERE
11010	Centers for Disease Control and Prevention	Html	en	Meningococcal | Technical and Clinical Info | CDC	Meningococcal Disease: Technical and Clinical Information Chart and Resources on Meningococcal Vaccination.	small portion 0.375984 PNH 0.314781 stiff neck 0.378971 long-term disabilities 0.366953 case patients 0.364867 incomplete protection 0.363431 increased risk 0.375259 paroxysmal nocturnal hemoglobinuria 0.422901 adolescents 0.326555 Neisseria meningitidis 0.391156 incidence rate 0.368874 brain damage 0.366203 age groups 0.410491 eculizumab patients 0.360297 graph 0.326357 nervous system problems 0.368153 meningococcal disease 0.949259 highest risk 0.370507 late 1990s 0.372462 medical conditions 0.416274 young adults 0.369709 higher rates 0.363317 sepsis 0.317388 meningococcal meningitis cases 0.680646 invasive meningococcal disease 0.616601	United States 0.441175 throat secretions 0.37286 total cases 0.370758 prophylaxis 0.335637 hemolytic uremic syndrome 0.422926 meningococcal vaccines 0.550869 lengthy contact 0.365167 sub-Saharan Africa 0.374303 reportable condition 0.366864 following groups 0.35975 close contact 0.370464 meningococcal vaccination recommendations 0.594263 local health departments 0.414449 meningococcal disease surveillance 0.618337 highest rates 0.372975 people 0.361834 certain medical conditions 0.413526 rash 0.316019 meningitis belt 0.375999 Recent data 0.36297 close contacts 0.427891 meningococcal bacteria 0.569786 household 0.324215 multiple serogroups 0.375539	CLICK HERE
11029	Centers for Disease Control and Prevention	Html	en	The 25th Anniversary of the Discovery of the Hepatitis CVirus: Looking Back to Look Forward | Public Health Grand Rounds 'CDC	Pre-Exposure Prophylaxis for Prevention of HIV - CDC	Health Grand Rounds 0.909643 blood products 0.494934 STD 0.415781 CDC 0.435582 MPH 0.46096 San Francisco Department 0.541103 HCV-infected persons 0.569007 Phillip O. Coffin 0.546216 therapeutic advances 0.568859 Susan Laird 0.478095 blood borne infection 0.60512 spite 0.420783 successes 0.416787 MD 0.46198 Recent therapeutic advances 0.562618 National Center 0.481336 TB Prevention 0.484668 hepatitis C. 0.561132 isolation 0.415251 Viral Hepatitis 0.592155 Stanhope Bayne Jones 0.55838 Curative Era 0.484581 decrease 0.419219 Communications Director 0.484563 Public Health Grand 0.573476	David Thomas 0.479884 new screening guidelines 0.553442 new infections 0.486583 Public Health 0.706895 HCV infection 0.774925 United States 0.488021 progression 0.415064 virus 0.429021 Hopkins School 0.477387 individual outcomes 0.483518 Deputy Scientific Director 0.553539 pivotal role 0.501905 Public Health University 0.554535 testing methods 0.483328 implementation 0.415197 rates 0.415124 Thorpe 0.41529 p.m 0.419634 Medicine 0.422323 California San Francisco 0.54071 Infectious Diseases Johns 0.542439 Substance Use Research 0.476354 discovery 0.415266 John Iskander 0.487673	CLICK HERE
11322	Centers for Disease Control and Prevention	Html	null	Evidence Reviews and Research Summaries	This page provides tools and resources for researching and evaluating health literacy practice.			CLICK HERE
13529	Centers for Disease Control and Prevention	Html	en	Contact Lens Health Week - August 24-28, 2015	August 24–28, 2015, marks the second annual Contact Lens Health Week. In collaboration with partners from clinical, public health, industry, and regulatory sectors, CDC is promoting healthy contact lens wear and care practices to reduce the risk for eye infections and complications associated with poor contact lens hygiene.	proper wear 0.252547 Human Services 0.285323 MMWR HTML versions 0.287915 U.S. Department 0.283035 electronic PDF version 0.283863 population-based estimate 0.256763 contact lenses 0.313167 proper care 0.261894 Additional information 0.249316 costly eye infections 0.315842 Contact Lens Health 0.504461 Contact GPO 0.276082 healthy contact lens 0.446146 commercial sources 0.248819 care practices 0.259189 current prices 0.247044 eye doctor 0.256189 regulatory sectors 0.255251 lens hygiene habits 0.482367 poor contact lens 0.445431 original paper copy 0.28543 annual Contact Lens 0.45067 significant proportion 0.250421 contact lens hygiene 0.683114	Proper contact lens 0.418061 contact lens wearers 0.941133 United States 0.307708 U.S. Government Printing 0.289525 original MMWR paper 0.286341 vision problems 0.250608 regular visits 0.248318 lens hygiene habit 0.407335 MMWR readers 0.250964 character translation 0.246595 safer contact lens 0.43027 contact lens wear 0.515496 public health 0.260946 format errors 0.245891 painful eye 0.262192 higher risk 0.251024 observance targets 0.24957 typeset documents 0.248129 trade names 0.248849 contact lens compliance 0.416473 official text 0.246073 U.S. population 0.250165 non-CDC sites 0.247849 eye infections 0.402606	CLICK HERE
14117	Centers for Disease Control and Prevention	Html	en	HIV Testing and Service Delivery Among Black Females - 61Health Department Jurisdictions, United States, 2012-2014 |MMWR	The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).	HIV testing events 0.315599 National HIV/AIDS Strategy 0.267799 CDC-funded HIV testing 0.267699 new HIV infections 0.262652 HIV testing event 0.219736 United States 0.22978 HIV testing services 0.270059 widespread HIV testing 0.237405 Evaluation HIV testing 0.220162 HIV positivity rate 0.303243 HIV positivity rates 0.225337 HIV infections 0.390291 HIV testing events† 0.235588 HIV infection status 0.217197 HIV testing efforts 0.220431 hiv prevention program 0.374372 new HIV 0.275991 HIV diagnoses 0.217204 HIV positivity 0.307596	HIV testing programs 0.22581 health departments 0.253221 newly diagnosed HIV 0.721728 local health departments 0.232578 HIV transmission 0.217578 NHM&E HIV testing 0.233784 testing events 0.346074 HIV prevention services 0.245149 partner services 0.273755 HIV medical care 0.910229 black females 0.582578 HIV testing activities 0.235245 HIV surveillance data 0.231399 Prevention Program Monitoring 0.238854 HIV testing data 0.258483 National HIV Prevention 0.330619 HIV testing 0.48524 current HIV status 0.214852 HIV test date 0.21277	CLICK HERE
15654	Centers for Disease Control and Prevention	Html	null	Zika Virus	Zika Virus - CDC Newsroom			CLICK HERE